X4 Pharmaceuticals, Inc

XFOR

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001501697

SEC filings (opens in a new tab)

In the last 90 days, X4 Pharmaceuticals, Inc insiders filed 0 open-market purchases and 3 sales; 89 institutions reported holding it in 13F filings for Q2 2026, worth $463.0M in total; no superinvestor holds it.

Superinvestors holding XFOR, Q2 2026

See all superinvestors

No superinvestor reported holding XFOR in Q2 2026.